Presence of pus in a hollow organ or body cavity.
Suppurative inflammation of the pleural space.
An intracranial or rarely intraspinal suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID.
Empyema due to MYCOBACTERIUM TUBERCULOSIS.
Surgical procedure involving the creation of an opening (stoma) into the chest cavity for drainage; used in the treatment of PLEURAL EFFUSION; PNEUMOTHORAX; HEMOTHORAX; and EMPYEMA.
Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
'Pleural diseases' is a broad term referring to various medical conditions that affect the pleura, the thin, double-layered membrane surrounding the lungs, including inflammation (pleurisy), effusions (excess fluid buildup), thickening, or tumors, which may cause chest pain, coughing, and breathing difficulties.
The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy.
Endoscopic surgery of the pleural cavity performed with visualization via video transmission.
An abnormal passage or communication between a bronchus and another part of the body.
The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.
Surgical incision into the chest wall.
Surgical removal of ribs, allowing the chest wall to move inward and collapse a diseased lung. (Dorland, 28th ed)
Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.
Endoscopic examination, therapy or surgery of the pleural cavity.
Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.
Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.
The excision of lung tissue including partial or total lung lobectomy.
The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.
Hemorrhage within the pleural cavity.
Abnormal passage communicating with the STOMACH.

Primary distension of the guttural pouch lateral compartment secondary to empyema. (1/139)

A 6-year-old, 420-kg quarter horse gelding was presented with a 2-month history of difficulty swallowing and dyspnea. The horse was diagnosed with a right guttural pouch empyema with many large chondroids. Two surgeries were required to completely remove all the chondroids from what proved to be a primary distension of the guttural pouch lateral compartment.  (+info)

Effect of zinc-reversible growth-inhibitory activity in human empyema fluid on antibiotic microbicidal activity. (2/139)

Abscess fluid supernatants have zinc-reversible microbial growth-inhibitory activity that is mediated by calprotectin, a zinc-binding protein. Because it inhibits microbial growth, this activity might interfere with killing by antibiotics that require their target organisms to be proliferating. In the present study, we cultured bacteria in human empyema fluid and used zinc to overcome the growth-inhibitory effect of calprotectin. We then compared the effect of zinc on killing by the beta-lactams ampicillin and cefazolin with that of the fluoroquinolone trovafloxacin, since the latter may be better able to kill nonproliferating organisms. In empyema fluid diluted 1:5 in normal saline, addition of zinc (30 microM) increased growth of two strains of Staphyloccocus aureus and two strains of Escherichia coli but did not affect the MICs or MBCs of the three antibiotics in Mueller-Hinton broth. For one strain of S. aureus, no effect of zinc was found on killing by either ampicillin or cefazolin. However, with the other strain of S. aureus and both strains of E. coli, significant enhancement of killing by both drugs was observed with zinc addition. On the other hand, no effect on the killing of any of the organisms was observed for trovafloxacin when zinc was added. These results suggest that the zinc-reversible growth-inhibitory activity of abscess fluid may interfere with the microbicidal activity of antibiotics requiring proliferating target organisms, although antibiotics better able to kill nonproliferating organisms may be less affected by this phenomenon.  (+info)

Pharmacokinetics of trimethoprim-sulfamethoxazole in children. (3/139)

The present report extends experience with the use of trimethoprim-sulfamethoxazole (TMP-SMX) in children aged 3 months to 10 years. The regimen was TMP (200 mg)--SMX (1000 mg)/m-2d given in two equal doses. The drug was easily administered, well tolerated and efficacious in the treatment of a variety of infections in 12 children. A steady state had been achieved by the third dose of medication and accumulation of either component during days 1 through 4 did not occur. Serum concentrations of TMP were slightly lower in children aged less than 3 years compared with those aged 3 to 6 years but the differences were small and these results are preliminary. Peak mean serum TMP concentration was highest at day 3 when it reached 1.63 mug/ml. It is concluded that this regimen may be suboptimal for some major parenchymal infections even though the therapeutic result was excellent in most children.  (+info)

Rapid diagnosis of infectious pleural effusions by use of reagent strips. (4/139)

Reagent strips have not yet been tested for use in the diagnosis of infectious pleural effusions. A reagent strip was used to evaluate 82 patients with pleural effusions: 20 patients had transudative effusions, 35 had infectious exudative effusions (empyema in 14 and parapneumonic effusion in 21), and 27 had noninfectious exudative effusions. Pleural fluid protein, as evaluated by the reagent strip, proved accurate for the detection of exudative effusions (sensitivity, 93.1%; specificity, 50%; positive predictive value, 84.3%; negative predictive value, 71.5%; odds ratio [OR], 6.77; and 95% confidence interval [CI], 1.87-24). The reagent strip leukocyte esterase test effectively detected infectious exudative effusions (sensitivity, 42.8%; specificity, 91.3%; positive predictive value, 88.2%; negative predictive value, 51.2%; OR, 4.46; and 95% CI, 1.2-16.4). Pleural pH was significantly predicted by the reagent strip but was of no assistance in categorization of exudative effusions as infectious or noninfectious. Compared with physical, laboratory, and microbiological data, the reagent strip was as accurate for estimation of percentages of infectious and noninfectious exudative effusions. Thus, reagent strips may be a rapid, easy-to-use, and inexpensive technique for discriminating transudative from exudative pleural effusions and for categorizing exudative pleural effusions as infectious or noninfectious.  (+info)

Empyema in rheumatoid arthritis. (5/139)

Case notes of the last 67 patients to present at the Brompton Hospital with nontuberculous empyemas, and without malignant disease, have been examined. Three cases of empyema in association with rheumatoid arthritis (RA) were found, and these cases are reported. Previous literature concerning this association is reviewed. It is concluded that two types of empyema may occur in patients with RA. Some develop in association with nodular pleuropulmonary disease and the formation of pyopneumothoraces; in other cases large, recurrent, primary empyemas build up in the presence of active rheumatoid disease alone. As with rheumatoid pleural effusions, middle-aged men seem to be particularly susceptible.  (+info)

Evarts Ambrose Graham, empyema, and the dawn of clinical understanding of negative intrapleural pressure. (6/139)

The concept of negative intrapleural pressure is fairly new. Although the phenomenon had already been described, Wirz provided the first definitive analysis of its significance to the mechanics of breathing in 1923. By contrast, empyema has been known since antiquity; from the time of Hippocrates, treatment has consisted of open drainage. Open drainage was often successful and did not result in pneumothorax, because most cases of empyema were associated with adhesions and thickened visceral pleura that prevented the lung from collapsing. The epidemic of group A streptococcal pneumonia in military camps in 1917-1918 was associated with the rapid and early accumulation of empyema fluid and was the catalyst for renewed study of empyema. Use of open drainage to manage this illness resulted in a high immediate mortality rate, probably because patients developed pneumothorax. The work of Evarts Graham and the Empyema Commission married physiological understanding of pleural mechanics with rational clinical treatment and paved the way for further advances in thoracic surgery.  (+info)

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. (7/139)

We investigated the increasing incidence of pediatric empyema during the 1990s at Primary Children's Medical Center in Salt Lake City. Of 540 children hospitalized with community-acquired bacterial pneumonia (CAP) who were discharged from 1 July 1993 through 1 July 1999, 153 (28.3%) had empyema. The annual population incidence of empyema increased during the study period from 1 to 5 cases per 100,000 population aged <19 years. Streptococcus pneumoniae was identified as the most common cause of CAP with or without empyema; serotype 1 accounted for 50% of the cases of pneumococcal empyema. Patients with empyema were more likely to be >3 years old, to have > or =7 days of fever, to have varicella, and to have received antibiotics and ibuprofen before admission to the hospital, compared with patients without empyema (P<.0001 for each factor). The increasing incidence of empyema was associated with infection due to S. pneumoniae serotype 1, outpatient treatment with certain antibiotics, ibuprofen use, and varicella.  (+info)

Randomised trial of intrapleural urokinase in the treatment of childhood empyema. (8/139)

BACKGROUND: The role of intrapleural fibrinolytic agents in the treatment of childhood empyema has not been established. A randomised double blind placebo controlled trial of intrapleural urokinase was performed in children with parapneumonic empyema. METHODS: Sixty children (median age 3.3 years) were recruited from 10 centres and randomised to receive either intrapleural urokinase 40 000 units in 40 ml or saline 12 hourly for 3 days. The primary outcome measure was length of hospital stay after entry to the trial. RESULTS: Treatment with urokinase resulted in a significantly shorter hospital stay (7.4 v 9.5 days; ratio of geometric means 1.28, CI 1.16 to 1.41 p=0.027). A post hoc analysis showed that the use of small percutaneous drains was also associated with shorter hospital stay. Children treated with a combination of urokinase and a small drain had the shortest stay (6.0 days, CI 4.6 to 7.8). CONCLUSION: Intrapleural urokinase is effective in treating empyema in children and significantly shortens hospital stay.  (+info)

Empyema is a medical condition characterized by the accumulation of pus in a body cavity, most commonly in the pleural space surrounding the lungs. It is usually caused by a bacterial infection that spreads from the lung tissue to the pleural space. The buildup of pus can cause chest pain, cough, fever, and difficulty breathing. Empyema can be a complication of pneumonia or other respiratory infections, and it may require treatment with antibiotics, drainage of the pus, and sometimes surgery.

Empyema is a collection of pus in a body cavity. Pleural empyema refers to the presence of pus in the pleural space, which is the thin fluid-filled space that surrounds the lungs. This condition usually develops as a complication of pneumonia or lung infection, and it can cause symptoms such as chest pain, cough, fever, and difficulty breathing. Treatment typically involves antibiotics to treat the underlying infection, as well as drainage of the pus from the pleural space through procedures such as thoracentesis or chest tube placement. In severe cases, surgery may be necessary to remove the infected pleura and prevent recurrence.

Empyema subdural is a medical condition characterized by the presence of pus (purulent material) in the potential space between the dura mater and the arachnoid membrane of the brain. This space is called the subdural space. Empyema subdural can result from an infection that spreads from nearby areas such as the skull, face, or sinuses, or it can occur as a complication of neurosurgical procedures.

The symptoms of empyema subdural may include headache, altered mental status, fever, seizures, and neurological deficits depending on the severity and location of the infection. Diagnosis is usually made with the help of imaging studies such as CT or MRI scans, and treatment typically involves surgical drainage of the pus along with antibiotic therapy to eliminate the underlying infection. If left untreated, empyema subdural can lead to serious complications such as brain abscess, meningitis, or even death.

Tuberculous empyema is a specific type of empyema, which is a collection of pus in the pleural space (the space between the lungs and the chest wall). It is caused by the Mycobacterium tuberculosis bacterium, which is the same bacterium that causes tuberculosis (TB) of the lungs.

In tuberculous empyema, the bacteria spread from the lungs to the pleural space, where they cause an infection and inflammation. This can lead to the accumulation of pus and the development of a chronic empyema. Symptoms may include chest pain, cough, fever, and difficulty breathing. Treatment typically involves a prolonged course of multiple antibiotics to kill the bacteria, as well as drainage of the pus from the pleural space. In some cases, surgery may be necessary to remove the infected tissue and prevent recurrence.

Thoracostomy is a surgical procedure that involves the creation of an opening into the chest cavity to relieve excessive pressure, drain fluid or air accumulation, or provide access for surgery. It is commonly performed to treat conditions such as pneumothorax (collapsed lung), hemothorax (blood in the chest cavity), pleural effusion (excess fluid in the pleural space), and empyema (pus in the pleural space).

During a thoracostomy, a healthcare professional makes an incision on the chest wall and inserts a tube called a thoracostomy tube or chest tube. The tube is connected to a drainage system that helps remove the air, fluid, or blood from the chest cavity. This procedure can be performed as an emergency treatment or as a planned surgical intervention.

The medical definition of thoracostomy includes the following key components:

1. A surgical procedure
2. Involving the creation of an opening
3. Into the chest cavity (thorax)
4. To relieve pressure, drain fluids or air, or provide access for surgery
5. Often performed with the insertion of a thoracostomy tube or chest tube
6. Used to treat various conditions related to the pleural space and lungs

Pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space, which is the thin, fluid-filled space that surrounds the lungs and lines the inside of the chest wall. This space typically contains a small amount of fluid to allow for smooth movement of the lungs during breathing. However, when an excessive amount of fluid accumulates, it can cause symptoms such as shortness of breath, coughing, and chest pain.

Pleural effusions can be caused by various underlying medical conditions, including pneumonia, heart failure, cancer, pulmonary embolism, and autoimmune disorders. The fluid that accumulates in the pleural space can be transudative or exudative, depending on the cause of the effusion. Transudative effusions are caused by increased pressure in the blood vessels or decreased protein levels in the blood, while exudative effusions are caused by inflammation, infection, or cancer.

Diagnosis of pleural effusion typically involves a physical examination, chest X-ray, and analysis of the fluid in the pleural space. Treatment depends on the underlying cause of the effusion and may include medications, drainage of the fluid, or surgery.

Pleural diseases refer to conditions that affect the pleura, which is the thin, double-layered membrane that surrounds the lungs and lines the inside of the chest wall. The space between these two layers contains a small amount of fluid that helps the lungs move smoothly during breathing. Pleural diseases can cause inflammation, infection, or abnormal collections of fluid in the pleural space, leading to symptoms such as chest pain, cough, and difficulty breathing.

Some common examples of pleural diseases include:

1. Pleurisy: Inflammation of the pleura that causes sharp chest pain, often worsened by breathing or coughing.
2. Pleural effusion: An abnormal accumulation of fluid in the pleural space, which can be caused by various underlying conditions such as heart failure, pneumonia, cancer, or autoimmune disorders.
3. Empyema: A collection of pus in the pleural space, usually resulting from a bacterial infection.
4. Pleural thickening: Scarring and hardening of the pleura, which can restrict lung function and cause breathlessness.
5. Mesothelioma: A rare form of cancer that affects the pleura, often caused by exposure to asbestos.
6. Pneumothorax: A collection of air in the pleural space, which can result from trauma or a rupture of the lung tissue.

Proper diagnosis and treatment of pleural diseases require a thorough evaluation by a healthcare professional, often involving imaging tests such as chest X-rays or CT scans, as well as fluid analysis or biopsy if necessary.

Drainage, in medical terms, refers to the removal of excess fluid or accumulated collections of fluids from various body parts or spaces. This is typically accomplished through the use of medical devices such as catheters, tubes, or drains. The purpose of drainage can be to prevent the buildup of fluids that may cause discomfort, infection, or other complications, or to treat existing collections of fluid such as abscesses, hematomas, or pleural effusions. Drainage may also be used as a diagnostic tool to analyze the type and composition of the fluid being removed.

Chest tubes are medical devices that are inserted into the chest cavity to drain fluid, air, or blood. They are typically used to treat conditions such as pneumothorax (collapsed lung), hemothorax (blood in the chest cavity), pleural effusion (excess fluid in the chest cavity), and chylothorax (milky fluid in the chest cavity).

Chest tubes are usually inserted between the ribs and directed into the chest cavity, allowing for drainage of the affected area. The tubes are connected to a collection system that creates negative pressure, which helps to remove the air or fluid from the chest cavity.

The size and number of chest tubes used may vary depending on the severity and location of the condition being treated. Chest tubes are typically removed once the underlying condition has been resolved and the drainage has decreased to a minimal amount.

Thoracic surgery, video-assisted (VATS) is a minimally invasive surgical technique used to diagnose and treat various conditions related to the chest cavity, including the lungs, pleura, mediastinum, esophagus, and diaphragm. In VATS, a thoracoscope, a type of endoscope with a camera and light source, is inserted through small incisions in the chest wall to provide visualization of the internal structures. The surgeon then uses specialized instruments to perform the necessary surgical procedures, such as biopsies, lung resections, or esophageal repairs. Compared to traditional open thoracic surgery, VATS typically results in less postoperative pain, shorter hospital stays, and quicker recoveries for patients.

A bronchial fistula is an abnormal connection or passage between the bronchial tree (the airways in the lungs) and the surrounding tissues, such as the pleural space (the space between the lungs and the chest wall), blood vessels, or other organs. This condition can result from various causes, including lung injury, infection, surgery, or certain diseases such as cancer or tuberculosis.

Bronchial fistulas can lead to symptoms like coughing, wheezing, shortness of breath, and chest pain. They may also cause air leaks, pneumothorax (collapsed lung), or chronic infections. Treatment for bronchial fistulas depends on the underlying cause and severity of the condition but often involves surgical repair or closure of the abnormal connection.

The pleura is the medical term for the double-layered serous membrane that surrounds the lungs and lines the inside of the chest cavity. The two layers of the pleura are called the parietal pleura, which lines the chest cavity, and the visceral pleura, which covers the surface of the lungs.

The space between these two layers is called the pleural cavity, which contains a small amount of lubricating fluid that allows the lungs to move smoothly within the chest during breathing. The main function of the pleura is to protect the lungs and facilitate their movement during respiration.

Thoracotomy is a surgical procedure that involves making an incision on the chest wall to gain access to the thoracic cavity, which contains the lungs, heart, esophagus, trachea, and other vital organs. The incision can be made on the side (lateral thoracotomy), back (posterolateral thoracotomy), or front (median sternotomy) of the chest wall, depending on the specific surgical indication.

Thoracotomy is performed for various indications, including lung biopsy, lung resection, esophagectomy, heart surgery, and mediastinal mass removal. The procedure allows the surgeon to directly visualize and access the organs within the thoracic cavity, perform necessary procedures, and control bleeding if needed.

After the procedure, the incision is typically closed with sutures or staples, and a chest tube may be placed to drain any accumulated fluid or air from the pleural space around the lungs. The patient will require postoperative care and monitoring in a hospital setting until their condition stabilizes.

Thoracoplasty is a surgical procedure that involves the removal or collapse of one or more ribs and the attached muscles from the chest wall. This procedure is typically performed to correct a deformity or to remove infected tissue in the chest cavity, such as in cases of chronic empyema (a collection of pus in the pleural space) or tuberculosis.

The removal of ribs can also help to reduce the size of an overexpanded lung, which can occur due to conditions like COPD (chronic obstructive pulmonary disease) or a bronchopleural fistula (an abnormal connection between the airways and the pleural space). Thoracoplasty can also be used for cosmetic purposes, such as in the treatment of pectus excavatum (a deformity where the breastbone is sunken into the chest).

A lung abscess is a localized collection of pus in the lung parenchyma caused by an infectious process, often due to bacterial infection. It's characterized by necrosis and liquefaction of pulmonary tissue, resulting in a cavity filled with purulent material. The condition can develop as a complication of community-acquired or nosocomial pneumonia, aspiration of oral secretions containing anaerobic bacteria, septic embolism, or contiguous spread from a nearby infected site.

Symptoms may include cough with foul-smelling sputum, chest pain, fever, weight loss, and fatigue. Diagnosis typically involves imaging techniques such as chest X-ray or CT scan, along with microbiological examination of the sputum to identify the causative organism(s). Treatment often includes antibiotic therapy tailored to the identified pathogen(s), as well as supportive care such as bronchoscopy, drainage, or surgery in severe cases.

Thoracoscopy is a surgical procedure in which a thoracoscope, a type of endoscope, is inserted through a small incision between the ribs to examine the lungs and pleural space (the space surrounding the lungs). It allows the surgeon to directly view the chest cavity, take biopsies, and perform various operations. This procedure is often used in the diagnosis and treatment of pleural effusions, lung cancer, and other chest conditions.

A fistula is an abnormal connection or passage between two organs, vessels, or body parts that usually do not connect. It can form as a result of injury, infection, surgery, or disease. A fistula can occur anywhere in the body but commonly forms in the digestive system, genital area, or urinary system. The symptoms and treatment options for a fistula depend on its location and underlying cause.

A respiratory tract fistula is an abnormal connection or passage between the respiratory tract (which includes the nose, throat, windpipe, and lungs) and another organ or structure, such as the skin, digestive tract, or blood vessels. This condition can lead to complications such as air leakage, infection, and difficulty breathing. The causes of respiratory tract fistulas vary and can include trauma, surgery, infection, or cancer. Treatment depends on the location and severity of the fistula and may involve surgical repair, antibiotics, or other therapies.

The pleural cavity is the potential space between the visceral and parietal pleura, which are the two membranes that surround the lungs. The visceral pleura covers the outside of the lungs, while the parietal pleura lines the inside of the chest wall. Under normal conditions, these two layers are in contact with each other, and the space between them is virtually nonexistent. However, when air, fluid or inflammation accumulates within this space, it results in the formation of a pleural effusion, which can cause discomfort and difficulty breathing.

A pneumonectomy is a surgical procedure in which an entire lung is removed. This type of surgery is typically performed as a treatment for certain types of lung cancer, although it may also be used to treat other conditions such as severe damage or infection in the lung that does not respond to other treatments. The surgery requires general anesthesia and can be quite complex, with potential risks including bleeding, infection, pneumonia, and air leaks. Recovery from a pneumonectomy can take several weeks, and patients may require ongoing rehabilitation to regain strength and mobility.

Instillation, in the context of drug administration, refers to the process of introducing a medication or therapeutic agent into a body cavity or onto a mucous membrane surface using gentle, steady pressure. This is typically done with the help of a device such as an eyedropper, pipette, or catheter. The goal is to ensure that the drug is distributed evenly over the surface or absorbed through the mucous membrane for localized or systemic effects. Instillation can be used for various routes of administration including ocular (eye), nasal, auricular (ear), vaginal, and intra-articular (joint space) among others. The choice of instillation as a route of administration depends on the drug's properties, the desired therapeutic effect, and the patient's overall health status.

Hemothorax is a medical condition characterized by the presence of blood in the pleural space, which is the area between the lungs and the chest wall. This accumulation of blood can occur due to various reasons such as trauma, rupture of a blood vessel, or complications from lung or heart surgery.

The buildup of blood in the pleural space can cause the affected lung to collapse, leading to symptoms such as shortness of breath, chest pain, and cough. In severe cases, hemothorax can be life-threatening if not promptly diagnosed and treated. Treatment options may include chest tube drainage, blood transfusion, or surgery, depending on the severity and underlying cause of the condition.

A gastric fistula is an abnormal connection or passage between the stomach and another organ or the skin surface. This condition can occur as a result of complications from surgery, injury, infection, or certain diseases such as cancer. Symptoms may include persistent drainage from the site of the fistula, pain, malnutrition, and infection. Treatment typically involves surgical repair of the fistula and management of any underlying conditions.

For example, pleural empyema is empyema of the pleural cavity. It must be differentiated from an abscess, which is a collection ... The term is from Greek ἐμπύημα, "abscess". Empyema occurs in: the pleural cavity (pleural empyema also known as pyothorax) the ... An empyema (/ˌɛmpaɪˈiːmə/) is a collection or gathering of pus within a naturally existing anatomical cavity. ... "The American Association for Thoracic Surgery consensus guidelines for the management of empyema". The Journal of Thoracic and ...
... as seen on ultrasound Pleural empyema as seen on ultrasound Pleural empyema as seen on ultrasound Pleural ... The initial investigations for suspected empyema remains chest X-ray, although it cannot differentiate an empyema from ... Pleural empyema is a collection of pus in the pleural cavity caused by microorganisms, usually bacteria. Often it happens in ... If however an empyema develops additional intervention is required. The clinical presentation of both the adult and pediatric ...
... is a form of empyema - a collection of pus, in the subdural space. Bacterial or occasionally fungal infection ... With treatment, including surgical drainage, resolution of the empyema occurs from the dural side, and, if it is complete, a ... The underlying arachnoid and subarachnoid spaces are usually unaffected, but a large subdural empyema may produce a mass effect ... Wu TJ, Chiu NC, Huang FY (February 2008). "Subdural empyema in center". J Microbiol Immunol Infect. 41 (1): 62-7. PMID 18327428 ...
... empyema. It may be fatal. Clinical sign and symptoms can be differ according to system it involves. features of systemic ...
Sat (2006-06-23). "Pulmonary Empyema". WebMD. Retrieved 2007-02-18. "Decortication: Background, Indications, Contraindications ...
An empyema is a Greek word derived from the word empyein which means "pus-producing". According to the Hippocratic Corpus, they ... Treating an empyema was primarily done using herbal remedies or non-invasive treatments. Mostly mixtures of plants and organic ... Physicians at the time thought that the cause of an empyema was by orally ingesting some form of foreign body where it will ... There are many symptoms associated with an empyema ranging from mild to severe. The most common ones are fever, thoracic pain, ...
... decortication for empyema; pleurodesis for recurrent pleural effusions or spontaneous pneumothorax; surgical stapler-assisted ...
It was originally intended to aid with drainage of tuberculous empyemas, since at the time there were no effective medications ... Prior to the development of the Eloesser flap in the 1930s, the main surgical treatments for chronic tuberculous empyema were ... The Eloesser flap is still utilized for patients with chronic empyemas who have not improved despite being treated with ... It is still used occasionally for chronic empyemas. As originally described by Dr. Eloesser, the procedure started with cutting ...
L'empyème pulsatile 1895 - Pulsatile empyema. Paralysies obstétricales des nouveau-nés, 1897 - Obstetrical paralyses of the new ...
Baracaldo, R.; Foltzer, M.; Patel, R.; Bourbeau, P. (2012). "Empyema Caused by Mycoplasma salivarium". Journal of Clinical ...
ELOESSER, L. (1935-10-01). "An Operation For Tuberculous Empyema". Diseases of the Chest. 1 (8): 8-23. doi:10.1378/chest.1.8.8 ... Eloesser, Leo (1969). "Of an Operation for Tuberculous Empyema". The Annals of Thoracic Surgery. 8 (4): 355-357. doi:10.1016/ ...
This is called an empyema. Pleural effusion involving fibrinous exudates in the fluid may be called fibrinous pleurisy, which ...
Neutrophils are numerous in pleural empyema. If lymphocytes predominate and mesothelial cells are rare, this is suggestive of ... empyema, pancreatitis, malignancy. Pink to red/bloody: Traumatic tap, malignancy, pulmonary infarction, intestinal infarction, ...
Roos KL, Tyler KL (2015). "Meningitis, Encephalitis, Brain Abscess, and Empyema". Harrison's Principles of Internal Medicine ( ...
Frontal sinusitis and empyema can also result. FHV-1 also has a predilection for corneal epithelium, resulting in corneal ...
pH is low in empyema (. WebPath images > "Inflammation". Heffner J, Brown L, Barbieri C (1997). "Diagnostic value of tests that ... By the origin of the fluid: Serous fluid (hydrothorax) Blood (haemothorax) Chyle (chylothorax) Pus (pyothorax or empyema) Urine ... more commonly known as pleural empyema), chyle (chylothorax), or very rarely urine (urinothorax). When unspecified, the term " ...
Complications may include empyema, sepsis, and septic shock. Chest tubes are contradicted, as they can cause loss of protein, ... Other possible complications may include pain, empyema, hemothorax, and subcutaneous emphysema. Additionally, repeat ...
Other pulmonary complications include lung abscess and empyema. Cardiovascular complications include cor pulmonale, in which ...
The empyema responded well to treatments however the splenic abscess required three weeks of drainage before the abscess ... Another study showed a case with a diagnosis of sympathetic empyema that was likely secondary to splenic abscess. Cultures of ... "Sympathetic Empyema Arising from Streptococcus anginosus Splenic Abscess." Southwest Journal of Pulmonary and Critical Care. ... Authors noted that there were no known cases of sympathetic empyema caused by Streptococcus anginosus. There are several ...
Dill SR, Cobbs CG, McDonald CK (February 1995). "Subdural empyema: analysis of 32 cases and review". Clinical Infectious ... subdural empyema, brain abscess and life-threatening cavernous sinus thrombosis. Infection of the eye socket is a rare ...
Occasionally, microorganisms will infect this fluid, causing an empyema. To distinguish an empyema from the more common simple ... In severe cases of empyema, surgery may be needed. If the infected fluid is not drained, the infection may persist, because ... If this shows evidence of empyema, complete drainage of the fluid is necessary, often requiring a drainage catheter. ... Yu H (March 2011). "Management of pleural effusion, empyema, and lung abscess". Seminars in Interventional Radiology. 28 (1): ...
Cannulae were used to heal ascites and empyema. This was done by using the bronze cannulae to make an incision into the abdomen ...
Stolk-Engelaar, Virginia; Verweil,Bongaerts,Linsen,Lacquet,Cox (July 1997). "Pleural empyema due to Clostridium difficile and ...
The concept of chest drainage was first advocated by Hippocrates when he described the treatment of empyema by means of ... Catheter drainage is used for empyemas after chest-tube failure: vanSonnenberg E, Nakamoto SK, Mueller PR, Casola G, Neff CC, ... However, the technique was not widely used until the influenza epidemic of 1918 to evacuate post-pneumonic empyema, which was ... Graham ME, Bell CR (1918). "Open Pneumothorax: Its relation to the treatment of empyema". J Med Sci. 156 (6): 839-871. doi: ...
The immediate cause of death was a heart attack; the long term cause was bronchitis and related empyema. University of Sydney ...
Miller E.S., Dias P. Uttley D. Subdural empyema; A review of 24 cases. Journal of Neurology, Neurosurgery and Psychiatry. 1987; ...
In rare cases, it has been linked to meningitis, pneumonia, empyema, endocarditis, and sepsis. These bacteria are gram-negative ... Isolation via a transthoracic pulmonary fine-needle aspiration identified N. flavescens as the cause of pneumonia and empyema ... "Necrotizing pneumonia and empyema caused by Neisseria flavescens infection". Journal of Thoracic Disease. 6 (5): 553-557. doi: ...
"Bacterial Causes of Empyema in Children, Australia, 2007-2009". Emerging Infectious Diseases. 17 (10): 1839-45. doi:10.3201/ ... "A Bedside Assay to Detect Streptococcus Pneumoniae in Children with Empyema". Pediatric Pulmonology. 46 (2): 179-83. doi: ...
Empyema is often secondary to guttural pouch tympany (distention of the pouches with air) in foals and weanlings. Arabians, in ... Guttural pouch empyema is characterized by the accretion of purulent, bacteria infested exudate in the pouch. The bacteria is ... In mild, acute cases of empyema, a saline or polyionic solution lavage is often performed via an endoscope or catheter ... Dixon, P. M.; James, O. A. (2016-12-01). "Equine guttural pouch empyema, why does it become chronic?" (PDF). Equine Veterinary ...
Osborn, Melissa K; Steinberg, James P (January 2007). "Subdural empyema and other suppurative complications of paranasal ... Sahjpaul, RL; Lee, DH (April 1999). "Infratentorial subdural empyema, pituitary abscess, and septic cavernous sinus ... or subdural empyema. People with CST are usually treated with prolonged courses (3-4 weeks) of IV antibiotics. If there is ...

No FAQ available that match "empyema"

No images available that match "empyema"